Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Esophageal Candidiasis in an Adolescent Who Had Frequently Received Budesonide Nebulizing Therapy

  • Kang, Hae Ryong (Department of Pediatrics, Hanyang University College of Medicine) ;
  • Kwon, Yong Hoon (Department of Pediatrics, Hanyang University College of Medicine) ;
  • Kim, Yong Joo (Department of Pediatrics, Hanyang University College of Medicine)
  • Received : 2013.06.16
  • Accepted : 2013.08.12
  • Published : 2013.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Corticosteroid (budesonide) nebulizer therapy is commonly performed. Its side effects have been considered as being safe or ignorable. The authors present a case of esophageal candidiasis in a healthy female adolescent who was treated with budesonide nebulizer therapy a few times for a cough during the previous winter season. This child presented with dysphagia and epigastric pain for 1 month. Esophageal endoscopy showed a whitish creamy pseudomembrane and erosions on the esophageal mucosa. Pathologic findings showed numerous candidal hyphae. She did not show any evidence of immunodeficiency, clinically and historically. The esophageal lesion did not resolve naturally. The esophageal lesion completely improved with the antifungal therapy for 2 weeks; the symptoms disappeared, and the patient returned to normal health. It is important that frequent esophageal exposure to topical corticosteroids application can cause unexpected side effects.

Keywords

References

  1. Mullaoglu S, Turktas H, Kokturk N, Tuncer C, Kalkanci A, Kustimur S. Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. Allergy Asthma Proc 2007;28:544-9. https://doi.org/10.2500/aap2007.28.3046
  2. Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis--an adverse effect of inhaled corticosteroids therapy. J Asthma 2009;46:399-401. https://doi.org/10.1080/02770900902777783
  3. Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl) 2010;2:89-101.
  4. Misra S, Ament ME. Esophagitis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Saunders, 1997:562-6.
  5. Kliemann DA, Pasqualotto AC, Falavigna M, Giaretta T, Severo LC. Candida esophagitis: species distribution and risk factors for infection. Rev Inst Med Trop Sao Paulo 2008;50:261-3. https://doi.org/10.1590/S0036-46652008000500002
  6. Mathieson R, Dutta SK. Candida esophagitis. Dig Dis Sci 1983;28:365-70. https://doi.org/10.1007/BF01324956
  7. Kanda N, Yasuba H, Takahashi T, Mizuhara Y, Yamazaki S, Imada Y, et al. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol 2003;98:2146-8. https://doi.org/10.1111/j.1572-0241.2003.07626.x
  8. Shuto H, Nagata M, Terashi Y, Yamaguchi M, Takizawa T, Shuto C, et al. Esophageal candidiasis as complication of inhaled steroid therapy. Arerugi 2003;52:1053-64.
  9. Kim YJ, Jang SJ. A case of esophageal candidiasis presenting recurrent abdominal pain in animmunecompetent child. Korean J Gastrointest Endosc 1997;17:55-8.
  10. Hasosah MY, Showail M, Al-Sahafi A, Satti M, Jacobson K. Esophageal candidiasis in an immunocompetent girl. World J Pediatr 2009;5:152-4. https://doi.org/10.1007/s12519-009-0031-4
  11. Ostrosky-Zeichner L, Rex JH, Bennett J, Kullberg BJ. Deeply invasive candidiasis. Infect Dis Clin North Am 2002;16:821-35. https://doi.org/10.1016/S0891-5520(02)00034-X